Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|December 8, 2006
Urinary albumin excretion and the renin-angiotensin system in cardiovascular risk managementR M A Van de Wal, A A Voors, R T Gansevoort
European Heart Journal|August 18, 2005
Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?Ruud M A van de Wal, Dirk J van Veldhuisen, Wiek H van Gilst, et al.
Psycho-Oncology|October 31, 2012
Chemotherapy and cognitive complaints in women with breast cancerMarleen J J Pullens, Jolanda De Vries, Laurence J C Van Warmerdam, et al.
The Journal of Pathology|August 10, 1999
Cellular localization and tissue distribution of polycystin-1D J Peters, A van de Wal, L Spruit, et al.
Cardiovascular Drugs and Therapy|March 17, 2005
New pharmacological strategies in chronic heart failureR M A van de Wal, A A Voors, H W M Plokker, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 10, 2007
Giant aneurysm of an aortocoronary venous bypass graft compressing the right ventricleR M A van de Wal, J W van Werkum, M-C le Cocq d'Armandville, et al.
Journal of Cardiac Failure|October 19, 2005
High prevalence of microalbuminuria in chronic heart failure patientsRuud M A van de Wal, Folkert W Asselbergs, H W Thijs Plokker, et al.
Circulation|September 21, 2005
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failurePeter van der Meer, Erik Lipsic, B Daan Westenbrink, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 22, 2008
Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjectsRuud M A van de Wal, Pim van der Harst, Wim B M Gerritsen, et al.
Pageof 2